Loading…
MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells
Abstract Clear cell renal cell carcinoma (ccRCC) is the major and aggressive subtype of RCC. Previously, we identified 383 differentially expressed genes by analyzing full-length cDNA libraries of ccRCC and normal kidney tissues. In this study, we applied functional network analysis to the different...
Saved in:
Published in: | Cancer letters 2009-01, Vol.273 (1), p.35-43 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633 |
---|---|
cites | cdi_FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633 |
container_end_page | 43 |
container_issue | 1 |
container_start_page | 35 |
container_title | Cancer letters |
container_volume | 273 |
creator | Tang, Sai-Wen Chang, Wen-Hsin Su, Yih-Ching Chen, Yu-Chi Lai, Yen-Han Wu, Pei-Tzu Hsu, Chyong-Ing Lin, Wei-Chou Lai, Ming-Kuen Lin, Jung-Yaw |
description | Abstract Clear cell renal cell carcinoma (ccRCC) is the major and aggressive subtype of RCC. Previously, we identified 383 differentially expressed genes by analyzing full-length cDNA libraries of ccRCC and normal kidney tissues. In this study, we applied functional network analysis to the differentially expressed genes for identifying deregulated molecular pathways in ccRCC, and the results indicated that MYC showed a prominent role in the highest scoring network. The upregulation of MYC expression was validated in ccRCC tissues and cell lines. Furthermore, Knockdown of MYC expression by MYC -specific siRNA significantly inhibited the abilities of uncontrolled proliferation, anchorage-independent growth and arrested cell cycle in the G0/G1 phase in ccRCC cells. Moreover, we found that 37 differentially expressed genes were shown to be MYC-target genes, and the upregulation of the MYC-target genes BCL2 , CCND1 , PCNA , PGK1 , and VEGFA were demonstrated. The expression of these MYC-target genes was significantly correlated with the expression of MYC in ccRCC tissues, and knockdown of MYC also suppressed the expression of these MYC-target genes in ccRCC cells. The recruitment of MYC to the promoter regions of BCL2 , CCND1 , PCNA , PGK1 , and VEGFA was shown by Chromatin immunoprecipitation assay. These results suggest that MYC pathway is activated and plays an essential role in the proliferation of ccRCC cells. |
doi_str_mv | 10.1016/j.canlet.2008.07.038 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66727424</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383508005831</els_id><sourcerecordid>66727424</sourcerecordid><originalsourceid>FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633</originalsourceid><addsrcrecordid>eNqFUk2r1DAUDaL4xtF_IBIQ3LXeNE2abgQZnh_wxIW6cBVu01vM2EnHpPNk9v5wUzrw4G3eKgk59-TknMPYSwGlAKHf7kuHYaS5rABMCU0J0jxiG2GaqmhaA4_ZBiTUhTRSXbFnKe0BQNWNesquhDHQVrXcsH9ffu74Eedff_HMfeLoZn-LM_XcB-5GwsgdjSOPFHBctw6j82E6IMfQc0qJwuzz5TBFfozT6AeKOPsp8Gl4kGI5pufsyYBjoheXdct-fLj-vvtU3Hz9-Hn3_qZwCtq5wA61atBQKwwoMHWnejm0UrVdpXpUQje6qzVI6bqq7qAVg6y16rueOglayi17s_JmmX9OlGZ78GlRgIGmU7JaN1VTZ1-27PU94H46xSw_WaEWE41uq4yqV5SLU0qRBnuM_oDxbAXYJSO7t2tGdsnIQmNzRnns1YX81B2ovxu6hJIB71YAZS9uPUWbnKfgqPeR3Gz7yT_0wn0CN_rgHY6_6Uzp7i82VRbst6UnS03A5IYYKeR_xYq5WA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1505478692</pqid></control><display><type>article</type><title>MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells</title><source>ScienceDirect Journals</source><creator>Tang, Sai-Wen ; Chang, Wen-Hsin ; Su, Yih-Ching ; Chen, Yu-Chi ; Lai, Yen-Han ; Wu, Pei-Tzu ; Hsu, Chyong-Ing ; Lin, Wei-Chou ; Lai, Ming-Kuen ; Lin, Jung-Yaw</creator><creatorcontrib>Tang, Sai-Wen ; Chang, Wen-Hsin ; Su, Yih-Ching ; Chen, Yu-Chi ; Lai, Yen-Han ; Wu, Pei-Tzu ; Hsu, Chyong-Ing ; Lin, Wei-Chou ; Lai, Ming-Kuen ; Lin, Jung-Yaw</creatorcontrib><description>Abstract Clear cell renal cell carcinoma (ccRCC) is the major and aggressive subtype of RCC. Previously, we identified 383 differentially expressed genes by analyzing full-length cDNA libraries of ccRCC and normal kidney tissues. In this study, we applied functional network analysis to the differentially expressed genes for identifying deregulated molecular pathways in ccRCC, and the results indicated that MYC showed a prominent role in the highest scoring network. The upregulation of MYC expression was validated in ccRCC tissues and cell lines. Furthermore, Knockdown of MYC expression by MYC -specific siRNA significantly inhibited the abilities of uncontrolled proliferation, anchorage-independent growth and arrested cell cycle in the G0/G1 phase in ccRCC cells. Moreover, we found that 37 differentially expressed genes were shown to be MYC-target genes, and the upregulation of the MYC-target genes BCL2 , CCND1 , PCNA , PGK1 , and VEGFA were demonstrated. The expression of these MYC-target genes was significantly correlated with the expression of MYC in ccRCC tissues, and knockdown of MYC also suppressed the expression of these MYC-target genes in ccRCC cells. The recruitment of MYC to the promoter regions of BCL2 , CCND1 , PCNA , PGK1 , and VEGFA was shown by Chromatin immunoprecipitation assay. These results suggest that MYC pathway is activated and plays an essential role in the proliferation of ccRCC cells.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2008.07.038</identifier><identifier>PMID: 18809243</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Activation of MYC pathway ; Angiogenesis ; Apoptosis ; Blotting, Western ; Cancer ; Carcinoma, Renal Cell - genetics ; Carcinoma, Renal Cell - metabolism ; Carcinoma, Renal Cell - physiopathology ; Cell culture ; Cell cycle ; Cell Line, Tumor ; Cell Proliferation ; Clear cell renal cell carcinoma ; Full-length cDNA library ; Gene expression ; Gene Expression Regulation, Neoplastic ; Hematology, Oncology and Palliative Medicine ; Humans ; Immunohistochemistry ; Kidney Neoplasms - genetics ; Kidney Neoplasms - metabolism ; Kidney Neoplasms - physiopathology ; Kinases ; Knockdown of MYC ; Lymphoma ; Medical prognosis ; Phase transitions ; Proto-Oncogene Proteins c-myc - genetics ; Proto-Oncogene Proteins c-myc - metabolism ; Reproductive system ; Reverse Transcriptase Polymerase Chain Reaction ; RNA Interference ; RNA polymerase ; Rodents ; Signal Transduction ; Up-Regulation ; Vascular endothelial growth factor</subject><ispartof>Cancer letters, 2009-01, Vol.273 (1), p.35-43</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2008 Elsevier Ireland Ltd</rights><rights>Copyright Elsevier Limited Jan 8, 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633</citedby><cites>FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18809243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tang, Sai-Wen</creatorcontrib><creatorcontrib>Chang, Wen-Hsin</creatorcontrib><creatorcontrib>Su, Yih-Ching</creatorcontrib><creatorcontrib>Chen, Yu-Chi</creatorcontrib><creatorcontrib>Lai, Yen-Han</creatorcontrib><creatorcontrib>Wu, Pei-Tzu</creatorcontrib><creatorcontrib>Hsu, Chyong-Ing</creatorcontrib><creatorcontrib>Lin, Wei-Chou</creatorcontrib><creatorcontrib>Lai, Ming-Kuen</creatorcontrib><creatorcontrib>Lin, Jung-Yaw</creatorcontrib><title>MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Abstract Clear cell renal cell carcinoma (ccRCC) is the major and aggressive subtype of RCC. Previously, we identified 383 differentially expressed genes by analyzing full-length cDNA libraries of ccRCC and normal kidney tissues. In this study, we applied functional network analysis to the differentially expressed genes for identifying deregulated molecular pathways in ccRCC, and the results indicated that MYC showed a prominent role in the highest scoring network. The upregulation of MYC expression was validated in ccRCC tissues and cell lines. Furthermore, Knockdown of MYC expression by MYC -specific siRNA significantly inhibited the abilities of uncontrolled proliferation, anchorage-independent growth and arrested cell cycle in the G0/G1 phase in ccRCC cells. Moreover, we found that 37 differentially expressed genes were shown to be MYC-target genes, and the upregulation of the MYC-target genes BCL2 , CCND1 , PCNA , PGK1 , and VEGFA were demonstrated. The expression of these MYC-target genes was significantly correlated with the expression of MYC in ccRCC tissues, and knockdown of MYC also suppressed the expression of these MYC-target genes in ccRCC cells. The recruitment of MYC to the promoter regions of BCL2 , CCND1 , PCNA , PGK1 , and VEGFA was shown by Chromatin immunoprecipitation assay. These results suggest that MYC pathway is activated and plays an essential role in the proliferation of ccRCC cells.</description><subject>Activation of MYC pathway</subject><subject>Angiogenesis</subject><subject>Apoptosis</subject><subject>Blotting, Western</subject><subject>Cancer</subject><subject>Carcinoma, Renal Cell - genetics</subject><subject>Carcinoma, Renal Cell - metabolism</subject><subject>Carcinoma, Renal Cell - physiopathology</subject><subject>Cell culture</subject><subject>Cell cycle</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Clear cell renal cell carcinoma</subject><subject>Full-length cDNA library</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Kidney Neoplasms - genetics</subject><subject>Kidney Neoplasms - metabolism</subject><subject>Kidney Neoplasms - physiopathology</subject><subject>Kinases</subject><subject>Knockdown of MYC</subject><subject>Lymphoma</subject><subject>Medical prognosis</subject><subject>Phase transitions</subject><subject>Proto-Oncogene Proteins c-myc - genetics</subject><subject>Proto-Oncogene Proteins c-myc - metabolism</subject><subject>Reproductive system</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA Interference</subject><subject>RNA polymerase</subject><subject>Rodents</subject><subject>Signal Transduction</subject><subject>Up-Regulation</subject><subject>Vascular endothelial growth factor</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFUk2r1DAUDaL4xtF_IBIQ3LXeNE2abgQZnh_wxIW6cBVu01vM2EnHpPNk9v5wUzrw4G3eKgk59-TknMPYSwGlAKHf7kuHYaS5rABMCU0J0jxiG2GaqmhaA4_ZBiTUhTRSXbFnKe0BQNWNesquhDHQVrXcsH9ffu74Eedff_HMfeLoZn-LM_XcB-5GwsgdjSOPFHBctw6j82E6IMfQc0qJwuzz5TBFfozT6AeKOPsp8Gl4kGI5pufsyYBjoheXdct-fLj-vvtU3Hz9-Hn3_qZwCtq5wA61atBQKwwoMHWnejm0UrVdpXpUQje6qzVI6bqq7qAVg6y16rueOglayi17s_JmmX9OlGZ78GlRgIGmU7JaN1VTZ1-27PU94H46xSw_WaEWE41uq4yqV5SLU0qRBnuM_oDxbAXYJSO7t2tGdsnIQmNzRnns1YX81B2ovxu6hJIB71YAZS9uPUWbnKfgqPeR3Gz7yT_0wn0CN_rgHY6_6Uzp7i82VRbst6UnS03A5IYYKeR_xYq5WA</recordid><startdate>20090108</startdate><enddate>20090108</enddate><creator>Tang, Sai-Wen</creator><creator>Chang, Wen-Hsin</creator><creator>Su, Yih-Ching</creator><creator>Chen, Yu-Chi</creator><creator>Lai, Yen-Han</creator><creator>Wu, Pei-Tzu</creator><creator>Hsu, Chyong-Ing</creator><creator>Lin, Wei-Chou</creator><creator>Lai, Ming-Kuen</creator><creator>Lin, Jung-Yaw</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20090108</creationdate><title>MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells</title><author>Tang, Sai-Wen ; Chang, Wen-Hsin ; Su, Yih-Ching ; Chen, Yu-Chi ; Lai, Yen-Han ; Wu, Pei-Tzu ; Hsu, Chyong-Ing ; Lin, Wei-Chou ; Lai, Ming-Kuen ; Lin, Jung-Yaw</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Activation of MYC pathway</topic><topic>Angiogenesis</topic><topic>Apoptosis</topic><topic>Blotting, Western</topic><topic>Cancer</topic><topic>Carcinoma, Renal Cell - genetics</topic><topic>Carcinoma, Renal Cell - metabolism</topic><topic>Carcinoma, Renal Cell - physiopathology</topic><topic>Cell culture</topic><topic>Cell cycle</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Clear cell renal cell carcinoma</topic><topic>Full-length cDNA library</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Kidney Neoplasms - genetics</topic><topic>Kidney Neoplasms - metabolism</topic><topic>Kidney Neoplasms - physiopathology</topic><topic>Kinases</topic><topic>Knockdown of MYC</topic><topic>Lymphoma</topic><topic>Medical prognosis</topic><topic>Phase transitions</topic><topic>Proto-Oncogene Proteins c-myc - genetics</topic><topic>Proto-Oncogene Proteins c-myc - metabolism</topic><topic>Reproductive system</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA Interference</topic><topic>RNA polymerase</topic><topic>Rodents</topic><topic>Signal Transduction</topic><topic>Up-Regulation</topic><topic>Vascular endothelial growth factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tang, Sai-Wen</creatorcontrib><creatorcontrib>Chang, Wen-Hsin</creatorcontrib><creatorcontrib>Su, Yih-Ching</creatorcontrib><creatorcontrib>Chen, Yu-Chi</creatorcontrib><creatorcontrib>Lai, Yen-Han</creatorcontrib><creatorcontrib>Wu, Pei-Tzu</creatorcontrib><creatorcontrib>Hsu, Chyong-Ing</creatorcontrib><creatorcontrib>Lin, Wei-Chou</creatorcontrib><creatorcontrib>Lai, Ming-Kuen</creatorcontrib><creatorcontrib>Lin, Jung-Yaw</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Sai-Wen</au><au>Chang, Wen-Hsin</au><au>Su, Yih-Ching</au><au>Chen, Yu-Chi</au><au>Lai, Yen-Han</au><au>Wu, Pei-Tzu</au><au>Hsu, Chyong-Ing</au><au>Lin, Wei-Chou</au><au>Lai, Ming-Kuen</au><au>Lin, Jung-Yaw</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2009-01-08</date><risdate>2009</risdate><volume>273</volume><issue>1</issue><spage>35</spage><epage>43</epage><pages>35-43</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Abstract Clear cell renal cell carcinoma (ccRCC) is the major and aggressive subtype of RCC. Previously, we identified 383 differentially expressed genes by analyzing full-length cDNA libraries of ccRCC and normal kidney tissues. In this study, we applied functional network analysis to the differentially expressed genes for identifying deregulated molecular pathways in ccRCC, and the results indicated that MYC showed a prominent role in the highest scoring network. The upregulation of MYC expression was validated in ccRCC tissues and cell lines. Furthermore, Knockdown of MYC expression by MYC -specific siRNA significantly inhibited the abilities of uncontrolled proliferation, anchorage-independent growth and arrested cell cycle in the G0/G1 phase in ccRCC cells. Moreover, we found that 37 differentially expressed genes were shown to be MYC-target genes, and the upregulation of the MYC-target genes BCL2 , CCND1 , PCNA , PGK1 , and VEGFA were demonstrated. The expression of these MYC-target genes was significantly correlated with the expression of MYC in ccRCC tissues, and knockdown of MYC also suppressed the expression of these MYC-target genes in ccRCC cells. The recruitment of MYC to the promoter regions of BCL2 , CCND1 , PCNA , PGK1 , and VEGFA was shown by Chromatin immunoprecipitation assay. These results suggest that MYC pathway is activated and plays an essential role in the proliferation of ccRCC cells.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>18809243</pmid><doi>10.1016/j.canlet.2008.07.038</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0304-3835 |
ispartof | Cancer letters, 2009-01, Vol.273 (1), p.35-43 |
issn | 0304-3835 1872-7980 |
language | eng |
recordid | cdi_proquest_miscellaneous_66727424 |
source | ScienceDirect Journals |
subjects | Activation of MYC pathway Angiogenesis Apoptosis Blotting, Western Cancer Carcinoma, Renal Cell - genetics Carcinoma, Renal Cell - metabolism Carcinoma, Renal Cell - physiopathology Cell culture Cell cycle Cell Line, Tumor Cell Proliferation Clear cell renal cell carcinoma Full-length cDNA library Gene expression Gene Expression Regulation, Neoplastic Hematology, Oncology and Palliative Medicine Humans Immunohistochemistry Kidney Neoplasms - genetics Kidney Neoplasms - metabolism Kidney Neoplasms - physiopathology Kinases Knockdown of MYC Lymphoma Medical prognosis Phase transitions Proto-Oncogene Proteins c-myc - genetics Proto-Oncogene Proteins c-myc - metabolism Reproductive system Reverse Transcriptase Polymerase Chain Reaction RNA Interference RNA polymerase Rodents Signal Transduction Up-Regulation Vascular endothelial growth factor |
title | MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A24%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MYC%20pathway%20is%20activated%20in%20clear%20cell%20renal%20cell%20carcinoma%20and%20essential%20for%20proliferation%20of%20clear%20cell%20renal%20cell%20carcinoma%20cells&rft.jtitle=Cancer%20letters&rft.au=Tang,%20Sai-Wen&rft.date=2009-01-08&rft.volume=273&rft.issue=1&rft.spage=35&rft.epage=43&rft.pages=35-43&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2008.07.038&rft_dat=%3Cproquest_cross%3E66727424%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c509t-aba657a8e91805084b5d3f9359b25da51676b46033cb24b091f3465dbdeb30633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1505478692&rft_id=info:pmid/18809243&rfr_iscdi=true |